About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered, the Centers for Disease Control and Prevention said in a statement.
FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder
